Monthly Prescribing Reference8h
Twice-Yearly Lenacapavir Gets Priority Review For HIV PrEP
The Food and Drug Administration (FDA) has accepted under Priority Review the New Drug Application (NDA) for lenacapavir, a long-acting HIV-1 capsid inhibitor, for the prevention of HIV as ...
unaids10h
How the shift in US funding is threatening both the lives of people affected by HIV and the community groups supporting them
In a joint survey by Aidsfonds, GNP+ and the Robert Carr Fund 22% of organizations reported increased experiences of discrimination, including reports of discrimination within healthcare settings, ...
Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using ...
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Canada6d
HIV and AIDS: Symptoms and treatment
Some people may not develop any symptoms after contracting HIV and could remain undiagnosed until the symptoms of AIDS appear. This could be up to 10 years later. However, 50% or more of people living ...